Key result
The timing of surgery in patients with asymptomatic mitral regurgitation remains controversial due to various causes of valve dysfunction and the lack of a precise measure of disease severity.
Why the study?
What is the optimal timing of surgery in patients with asymptomatic mitral regurgitation?
What is the optimal timing of surgery in patients with asymptomatic mitral regurgitation?
The timing of surgery in asymptomatic mitral regurgitation remains controversial due to varying etiologies and lack of precise severity measures.
Optimal timing for surgery in asymptomatic mitral regurgitation remains uncertain; leaves open need for precise severity metrics and prospective trials.
The use of an evidence-based approach to the treatment of valvular heart disease has been hampered by the lack of rigorous data on predictors of the clinical outcome. The timing of surgery in patients with asymptomatic mitral regurgitation has been especially controversial for two reasons: the various causes of valve dysfunction and the lack of a precise measure of disease severity.1 Clinical outcomes and approaches to treatment depend on the cause of valve dysfunction. For example, in patients with secondary mitral regurgitation owing to dilated cardiomyopathy or ischemic disease, the prognosis depends mainly on the underlying disease and valve surgery . . .
No takes yet. Share an insight, caveat, or question.
Otto et al. (2005) conducted an editorial in Asymptomatic mitral regurgitation. Surgery was evaluated. The timing of surgery in patients with asymptomatic mitral regurgitation remains controversial due to various causes of valve dysfunction and the lack of a precise measure of disease severity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: